Galvus is the anti-diabetic drug formulated by using Vildagliptin which was earlier recognized as LAF237. It is the latest oral hypoglycemic anti-diabetic drug from the new di-peptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Galvus or Vildagliptin restrains the inactivation of GLP-1 by DPP-4, permitting GLP-1 to potentiate the secretion of insulin in the beta cells. The drug is under the specific mandatory clinical trials and has been proving to decrease the hyperglycemia levels in the ...
| Currently you cannot purchase Gelvus as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Gelvus |
| Gelvus Availability Subscription Form |
|
| |
| Note: We will email you when Gelvus is available for sale online or in pharmacy in your country. |
|
|
|
|
